Alliance for Clinical Trials in Oncology

By  Aditi Pai 01:28 pm April 27, 2016
Dana Farber Cancer Institute has partnered with Fitbit to launch a two-year randomized study that will investigate the impact of weight loss on breast cancer recurrence. The study, called the Breast Cancer Weight Loss (BWEL) study, is sponsored by the National Cancer Institute and the Alliance for Clinical Trials in Oncology. “The increased risk of cancer recurrence linked to excess body weight...